85 related articles for article (PubMed ID: 16815198)
1. Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas.
Nazar G; González MV; García JM; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):135-9. PubMed ID: 16815198
[TBL] [Abstract][Full Text] [Related]
2. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
3. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
4. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.
Miller CT; Moy JR; Lin L; Schipper M; Normolle D; Brenner DE; Iannettoni MD; Orringer MB; Beer DG
Clin Cancer Res; 2003 Oct; 9(13):4819-25. PubMed ID: 14581353
[TBL] [Abstract][Full Text] [Related]
5. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
[TBL] [Abstract][Full Text] [Related]
6. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
7. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Bizari L; Borim AA; Leite KR; Gonçalves Fde T; Cury PM; Tajara EH; Silva AE
Cancer Genet Cytogenet; 2006 Feb; 165(1):41-50. PubMed ID: 16490596
[TBL] [Abstract][Full Text] [Related]
9. Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer.
Jehan Z; Bavi P; Sultana M; Abubaker J; Bu R; Hussain A; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Nov; 219(3):337-46. PubMed ID: 19697359
[TBL] [Abstract][Full Text] [Related]
10. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
Freier K; Sticht C; Hofele C; Flechtenmacher C; Stange D; Puccio L; Toedt G; Radlwimmer B; Lichter P; Joos S
Genes Chromosomes Cancer; 2006 Feb; 45(2):118-25. PubMed ID: 16235239
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment.
Cantù G; Bimbi G; Miceli R; Mariani L; Colombo S; Riccio S; Squadrelli M; Battisti A; Pompilio M; Rossi M
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):170-7. PubMed ID: 18283160
[TBL] [Abstract][Full Text] [Related]
14. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
15. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization in primary sinonasal adenocarcinomas.
Ariza M; Llorente JL; Alvarez-Marcas C; Baragaño L; Salas A; Rodriguez Prado N; Hermsen M; Suárez C; Sampedro A
Cancer; 2004 Jan; 100(2):335-41. PubMed ID: 14716769
[TBL] [Abstract][Full Text] [Related]
17. ras gene mutations in ethmoid sinus adenocarcinoma: prognostic implications.
Pérez P; Dominguez O; González S; González S; Triviño A; Suárez C
Cancer; 1999 Jul; 86(2):255-64. PubMed ID: 10421261
[TBL] [Abstract][Full Text] [Related]
18. Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands.
Sequeiros-Santiago G; García-Carracedo D; Fresno MF; Suarez C; Rodrigo JP; Gonzalez MV
Oncol Rep; 2009 May; 21(5):1215-22. PubMed ID: 19360297
[TBL] [Abstract][Full Text] [Related]
19. [Nasosinusal adenocarcinoma: molecular and genetic analysis by MLPA].
Llorente JL; Aldama P; Alvarez-Marcos C; Escudero J; Alonso-Guervós M; Fresno F; Suárez C; Hermsen M
Acta Otorrinolaringol Esp; 2008 Apr; 59(4):151-8. PubMed ID: 18447972
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarrays for gene amplification surveys in many different tumor types.
Schraml P; Kononen J; Bubendorf L; Moch H; Bissig H; Nocito A; Mihatsch MJ; Kallioniemi OP; Sauter G
Clin Cancer Res; 1999 Aug; 5(8):1966-75. PubMed ID: 10473073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
